SCHEMBL30737884

SCHEMBL30737884

CNC(=O)c1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 20/20 1.00
FGFR3 P22607 18/20 1.00
FGFR2 P21802 17/20 1.00
KDR P35968 17/20 1.00
FGFR4 P22455 16/20 1.00
FLT3 P36888 6/20 1.00
ADORA3 P0DMS8 1/20 0.68
CHRM1 P11229 1/20 0.68
ADRA2C P18825 1/20 0.68
SLC6A2 P23975 1/20 0.68
SLC6A4 P31645 1/20 0.68
DRD3 P35462 1/20 0.68
OPRD1 P41143 1/20 0.68
ETV6 P41212 1/20 0.68
HTR2B P41595 1/20 0.68
SLC6A3 Q01959 1/20 0.68
PDE4D Q08499 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12178503 1.00 FGFR1 (1.00) FGFR1FGFR3FGFR2KDRFGFR4
SCHEMBL12179158 0.92 FGFR1 (1.00) FGFR1FGFR3FGFR2KDRFGFR4
SCHEMBL30737782 0.92 FGFR1 (1.00) FGFR1FGFR3FGFR2KDRFGFR4
SCHEMBL12179221 0.90 FGFR1 (0.98) FGFR1FGFR3FGFR2KDRFGFR4
SCHEMBL12178466 0.85 FGFR1 (0.89) FGFR1FGFR3FGFR2KDRFGFR4
SCHEMBL12178539 0.84 FGFR1 (0.98) FGFR1FGFR3FGFR2KDRFGFR4
Hydrochloric Acid SCHEMBL27218162 0.84 FGFR1 (1.00) FGFR1FGFR3FGFR2KDRFGFR4
SCHEMBL2592981 0.84 FGFR1 (0.98) FGFR1FGFR3FGFR2KDRFGFR4
SCHEMBL18176332 0.82 FGFR3 (0.87) FGFR1FGFR3FGFR2KDRFGFR4
SCHEMBL26928219 0.82 FGFR1 (0.70) FGFR1FGFR3FGFR2KDRFGFR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023240271-A1 USE OF VEGFR2 AND FGFR1 INHIBITORS IN THERAPY FOUNTAIN THERAPEUTICS INC. (US) 2023-12-14 WO claimed
WO-2023240271-A1 USE OF VEGFR2 AND FGFR1 INHIBITORS IN THERAPY FOUNTAIN THERAPEUTICS INC. (US) 2023-12-14 WO disclosed